Hostname: page-component-74656f9884-rdgjk Total loading time: 0 Render date: 2026-11-08T08:24:45.077Z Has data issue: false hasContentIssue false

Farmers’ practices, motivators and barriers for adoption of treatments of digital dermatitis in dairy farms

Published online by Cambridge University Press:  01 May 2013

A. Relun
Affiliation:
Department Welfare Health Traceability and Hygiene, French Livestock Institute, F-75595 Paris, France Oniris, Nantes-Atlantic College of Veterinary Medicine and Food Sciences and Engineering, LUNAM Université, UMR Biologie Epidémiologie et Analyse de Risques, CS 40706, F-44307 Nantes, France INRA, UMR1300 BioEpAR, F-44307 Nantes, France
R. Guatteo*
Affiliation:
Oniris, Nantes-Atlantic College of Veterinary Medicine and Food Sciences and Engineering, LUNAM Université, UMR Biologie Epidémiologie et Analyse de Risques, CS 40706, F-44307 Nantes, France
M. M. Auzanneau
Affiliation:
Oniris, Nantes-Atlantic College of Veterinary Medicine and Food Sciences and Engineering, LUNAM Université, UMR Biologie Epidémiologie et Analyse de Risques, CS 40706, F-44307 Nantes, France INRA, UMR1300 BioEpAR, F-44307 Nantes, France
N. Bareille
Affiliation:
Oniris, Nantes-Atlantic College of Veterinary Medicine and Food Sciences and Engineering, LUNAM Université, UMR Biologie Epidémiologie et Analyse de Risques, CS 40706, F-44307 Nantes, France INRA, UMR1300 BioEpAR, F-44307 Nantes, France

Abstract

This study aimed to catalogue the digital dermatitis (DD) treatment practices used by French dairy farmers and to identify the motivators and barriers to the adoption of these treatments. A semi-structured survey was conducted involving 65 farmers in the main dairy production areas of France in the spring of 2009. The different treatment modalities implemented by farmers since the first diagnosis of DD in their herds were described. The reasons for adopting or abandoning these treatments were then investigated based on criteria of perceived effectiveness, labour, time, cost and toxicity related to their use. For individual treatments, farmers used 30 different products, applied through three different routes, for 1 to 21 consecutive days. For collective treatments, farmers used 31 products, applied through four different routes, at a rate ranging from once a day to once a year. Several products, especially antibiotics, were used without observing the manufacturer's instructions. The principal criteria for the adoption of a treatment was the perceived effectiveness in healing DD lesions and in limiting recurrence, while the principal barriers to adopting a treatment were the time and labour required for its application, followed by cost. Topical oxytetracycline treatments applied individually were used and adopted the most. They were perceived to be effective in healing DD lesions. However, these treatments were judged labour and time consuming, particularly when many animals had to be treated. Collective treatments combining formalin and copper sulphate often were applied topically using walk-though footbaths. These treatments often were judged to be insufficiently effective in healing DD lesions, difficult to implement, labour and time consuming and costly. The plethora of DD treatment practices and the misuse of some treatments could suggest that there is a lack of guidelines available to farmers on the optimal use and expected effectiveness of treatments. Clinical trials should be conducted to develop recommendations based on scientific rather than empirical data, and to identify the DD control measures which consume the least amount of time and labour.

Information

Type
Behaviour, welfare and health
Copyright
Copyright © The Animal Consortium 2013 
Figure 0

Table 1 Characteristics of 65 French dairy farms involved in a survey on digital dermatitis treatment practices

Figure 1

Table 2 Summary statistics for individual treatment protocols against digital dermatitis per route of administration used by 63 French dairy farmers since the diagnosis of the disease in their herd

Figure 2

Table 3 Main type of treatments used by 63 French dairy farmers for individual treatment of digital dermatitis

Figure 3

Table 4 Summary statistics for collective treatment protocols against digital dermatitis per route of administration used by 58 French dairy farmers since the diagnosis of the disease in their herd

Figure 4

Table 5 Main type of treatments used by 58 French dairy farmers for collective treatment of digital dermatitis

Figure 5

Table 6 Main reasons reported by 65 French dairy farmers for the adoption of a treatment protocol against digital dermatitis (DD) according to the route of application (most farmers adopted more than one treatment protocol and reported more than one reason for the adoption of a treatment protocol)

Figure 6

Table 7 Main reasons reported by 65 French dairy farmers for the abandonment of a treatment protocol against digital dermatitis (DD) according to the route of application (most farmers abandoned more than one treatment protocol and reported more than one reason for the abandonment of a treatment protocol)